Maxion Therapeutics
UK - CambridgeBiotechnology
Focus: Maxion Therapeutics is a UK-based biotechnology company specializing in miniproteins engineered into antibody loops, a novel modality for targeted therapeutics. The company is publicly traded but operates at a relatively early stage with minimal disclosed commercial products.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Maxion Therapeutics?
AI assessmentMaxion is a high-risk, technology-focused play suited only for scientists betting on miniprotein differentiation; hiring freeze and pipeline opacity make it unsuitable for near-term career progression.
Why Work Here
- Exposure to cutting-edge miniprotein technology—a differentiated modality with potential first-mover advantages in antibody loop engineering
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Maxion Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.